Rostec and the Marathon Group will open a center for the development of vaccines

Biopharmaceutical company “FORT” – a joint asset of the holding “national immunobiological company” rostec state Corporation and Marathon Group – will open a research center to develop vaccines. The specialized complex is planned to put into operation in November 2020.

The new center will consist of four laboratories: cell technologies, microbiological, virological and PCR laboratory. The total area of the complex is more than 1000 square meters. Investment in the project will exceed 400 million rubles

“The creation of high-tech research center opens new avenues for research in this area. From 2021 on its basis it is planned to launch the site for the production of pilot series of new vaccines with subsequent scaling of production”, – said the Executive Director of Rostec Oleg Yevtushenko.

The Director of “FORT” Pavel Vandyshev said that the focus research center will be the development of live virus vaccines and vaccine prophylaxis of influenza, based on cellular technologies.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]